new Corona virus disease 2019. new Corona virus disease 2019
Conditions
Interventions
Intervention 1: Intervention group: COVID-19 standard treatment based on the protocol recommended by the Ministry of Health for hospitalized patients (remdesivir, prophylactic anticoagulant, and low
Sponsors
Artesh University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Men and women above 18 years with positive PCR test for Covid-19 At least two of these findings: GGO>10%, SO220, at least one underlying disease (COPD, HF, HTN, DM, Asthma, Immunodeficiency) Conscious written consent to participate in the study
Exclusion criteria
Exclusion criteria: Covid vaccination history Participation in another clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ICU admision or intubation. Timepoint: During hospitalization, daily. Method of measurement: Evaluator report. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical symptoms(The degree of shortness of breath, cough intensity). Timepoint: During hospitalization, daily. Method of measurement: Symptoms by asking the patient as a scale indicator and signs by monitoring the patient by the assessor.;Inflammatory markers (ESR, CRP, LDH, WBC). Timepoint: before and after the 5 days intervention. Method of measurement: Quantitative laboratory measurements of blood samples.;Clinical examinations (RR, SO2). Timepoint: During hospitalization, daily. Method of measurement: Through clinical examination and use of pulse oximeter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSajjad Panahi
Artesh University of Medical Sciences
Outcome results
None listed